Clinical Trial Update: Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of GB001 recombinant peptide spray for mild recurrent aphthous ulcers, with the trial currently listed as active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphthous Stomatitis

Drugs mentioned

• GB001 recombinant peptide spray (GB001)

Snippet

Sponsor: Zhejiang Echon Biopharm Limited | Conditions: Healthy | Phase 2 | Status: ACTIVE_NOT_RECRUITING